Figure 3
Relationships between plasma PAI-1 and Ang II changes during imidapril in hypertensive patients with metabolic syndrome. *P<0.05 vs. baseline; **P<0.01 vs. baseline. Ang II, angiotensin II; PAI-1, plasminogen activator inhibitor.
Figure 3 | Hypertension Research
